Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.290
-0.030 (-2.27%)
At close: Jul 21, 2025, 4:00 PM
1.310
+0.020 (1.55%)
After-hours: Jul 21, 2025, 7:50 PM EDT
Evogene Market Cap
Evogene has a market cap or net worth of $11.48 million as of July 21, 2025. Its market cap has decreased by -64.68% in one year.
Market Cap
11.48M
Enterprise Value
21.25M
1-Year Change
-64.68%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $11.48M, a decrease of -59.02%. That is a compound annual growth rate of -4.89%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.79B |
| Johnson & Johnson | 393.87B |
| AbbVie | 334.31B |
| Novo Nordisk | 287.38B |
| UnitedHealth Group | 256.40B |
| Novartis AG | 223.49B |
| Abbott Laboratories | 215.17B |
| AstraZeneca | 214.61B |